IP Library › Granted Patent US 10,626,458
Granted Patent B2
US 10,626,458 · App. 16/435,362 · Granted Apr 21, 2020

Methods and systems for processing polynucleotides

Inventors: Christopher Hindson (Pleasanton, CA); Michael Schnall-Levin (Palo Alto, CA); Andrew Price (Dublin, CA); Paul Hardenbol (San Francisco, CA); Yuan Li (Dublin, CA)
Assignee: 10X GENOMICS, INC.
C12Q1/6874C12Q1/6806C12Q1/6855C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,626,458
App. No.
16/435,362
Granted
Apr 21, 2020
Kind
B2
Abstract

This disclosure provides methods and compositions for sample processing, particularly for sequencing applications. Included within this disclosure are bead compositions, such as diverse libraries of beads attached to large numbers of oligonucleotides containing barcodes. Often, the beads provides herein are degradable. For example, they may contain disulfide bonds that are susceptible to reducing agents. The methods provided herein include methods of making libraries of barcoded beads as well as methods of combining the beads with a sample, such as by using a microfluidic device.

Claims (51)

1. A composition comprising:

a plurality of beads comprising a plurality of oligonucleotide molecules covalently attached thereto;

wherein said plurality of oligonucleotide molecules comprises a plurality of barcode sequences;

wherein said plurality of beads comprises N×M beads;

wherein said plurality of barcode sequences comprises N×M different barcode sequences;

wherein each barcode sequence of said plurality of barcode sequences comprises a first barcode sequence segment (B1) and a second barcode sequence segment (B2);

wherein each oligonucleotide molecule of said plurality of oligonucleotide molecules comprises a sequence having the structure A-B1-L-B2-C, wherein (i) A is an adapter sequence, (ii) L is a linking sequence, and (iii) C is a capture sequence selected from the group consisting of a poly-T sequence, a random N-mer sequence, and a gene-specific primer sequence;

wherein said plurality of barcode sequences comprises: (i) M different first barcode sequence segments at least m nucleotides in length, and (ii) N different second barcode sequence segments at least n nucleotides in length; and

wherein M=96, N=96, m≥6, and n≥6.

2. The composition of claim 1 , wherein M=384 and N=384.

3. The composition of claim 1 , wherein said linking sequence is 1-10 nucleotides in length.

4. The composition of claim 1 , wherein said linking sequence is 2-6 nucleotides in length.

5. The composition of claim 1 , wherein said linking sequence is 10 or more nucleotides in length.

6. The composition of claim 1 , wherein said adapter sequence is identical across said plurality of oligonucleotide molecules.

7. The composition of claim 6 , wherein said adapter sequence comprises one or more functional sequences.

8. The composition of claim 7 , wherein said one or more functional sequences comprise a primer sequence or a primer binding sequence.

9. The composition of claim 8 , wherein said primer sequence or said primer binding sequence is a sequencing primer sequence or a sequencing primer binding sequence.

10. The composition of claim 9 , wherein said sequencing primer sequence or said sequencing primer binding sequence is a R1 sequence, a R2 sequence, a partial R1 sequence, or a partial R2 sequence.

11. The composition of claim 7 , wherein said one or more functional sequences comprise a sequence configured to attach to a flow cell of a sequencer.

12. The composition of claim 11 , wherein said sequence configured to attach to the flow cell of a sequencer is a P5 sequence, a P7 sequence, a partial P5 sequence, or a partial P7 sequence.

13. The composition of claim 1 , wherein said plurality of oligonucleotide molecules are single stranded.

14. The composition of claim 1 , wherein said plurality of beads are a plurality of gel beads.

15. The composition of claim 14 , wherein said plurality of gel beads are degradable upon application of a stimulus.

16. The composition of claim 15 , wherein said plurality of gel beads comprise a plurality of crosslinks that are degradable upon application of a stimulus.

17. The composition of claim 15 , wherein said stimulus is a thermal stimulus, a chemical stimulus, a biological stimulus, or a photo stimulus.

18. The composition of claim 16 , wherein said plurality of crosslinks comprise a disulfide bond and wherein said stimulus is a reducing agent.

19. The composition of claim 14 , wherein said plurality of oligonucleotides are releasable from said gel bead upon application of a stimulus.

20. The composition of claim 19 , wherein said plurality of oligonucleotide molecules are attached to said gel bead via a disulfide bond and wherein said stimulus is a reducing agent.

21. The composition of claim 1 , wherein said plurality of oligonucleotides are releasable from said bead upon application of a stimulus.

22. The composition of claim 21 , wherein said stimulus is a thermal stimulus, a chemical stimulus, a biological stimulus, or a photo-stimulus.

23. The composition of claim 22 , wherein said plurality of oligonucleotide molecules are attached to said bead via a disulfide bond and wherein said stimulus is a reducing agent.

24. The composition of claim 1 , wherein said plurality of beads comprises M×N×Z beads;

wherein said plurality of barcode sequences comprises M×N×Z different barcode sequences;

wherein each barcode sequence of said plurality of barcode sequences further comprises a third barcode sequence segment (B3);

wherein each oligonucleotide molecule of said plurality of oligonucleotide molecules comprises a sequence having the structure A-B1-L1-B2-L2-B3-C, wherein (i) L1 is a first linking sequence, and (ii) L2 is a second linking sequence;

wherein said plurality of barcode sequences further comprises: (i) Z different third barcode sequence segments at least z nucleotides in length; and

wherein Z=96 and z≥6.

25. The composition of claim 24 , wherein L1 and L2 are different sequences.

26. The composition of claim 24 , wherein L1 and L2 are each 1-10 nucleotides in length.

27. The composition of claim 24 , wherein L1 and L2 are each 10 or more nucleotides in length.

28. The composition of claim 1 , wherein said plurality of oligonucleotide molecules comprise a uracil containing nucleotide.

29. The composition of claim 1 , wherein each bead of said plurality of beads comprises 1,000,000 oligonucleotide molecules covalently attached thereto.

30. A composition comprising:

a plurality of beads comprising a plurality of oligonucleotide molecules covalently attached thereto;

wherein said plurality of oligonucleotide molecules comprises a plurality of barcode sequences;

wherein said plurality of beads comprises N×M beads;

wherein said plurality of barcode sequences comprises N×M different barcode sequences;

wherein each barcode sequence of said plurality of barcode sequences comprises a first barcode sequence segment (B1) and a second barcode sequence segment (B2);

wherein each oligonucleotide molecule of said plurality of oligonucleotide molecules comprises a sequence having the structure A-B1-L-B2-T, wherein (i) A is an adapter sequence, (ii) L is a linking sequence, and (iii) T is a poly-T sequence;

wherein said plurality of barcode sequences comprises: (i) M different first barcode sequence segments at least m nucleotides in length, and (ii) N different second barcode sequence segments at least n nucleotides in length; and

wherein M=96, N=96, m≥6, and n≥6.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2020
From: HINDSON, CHRISTOPHER; SCHNALL-LEVIN, MICHAEL; PRICE, ANDREW; HARDENBOL, PAUL; LI, YUAN
To: 10X GENOMICS, INC.
Reel/Frame 051827/0140 →
Continuity (23)
Continuation 16052486 · Aug 1, 2018
Continuation In Part 16000803 · Jun 5, 2018
Continuation 15850241 · Dec 21, 2017
Continuation 15588519 · May 5, 2017
Continuation 15376582 · Dec 12, 2016
Continuation In Part 14104650 · Dec 12, 2013
Continuation In Part 14250701 · Apr 11, 2014
Continuation 14175973 · Feb 7, 2014
Continuation In Part 14316447 · Jun 26, 2014
Continuation In Part 13996150 · Aug 13, 2013
Continuation In Part PCTUS2013054797 · Aug 13, 2013
Provisional Application 61737374 · Dec 14, 2012
Provisional Application 61844804 · Jul 10, 2013
Provisional Application 61840403 · Jun 27, 2013
Provisional Application 61800223 · Mar 15, 2013
Provisional Application 61762435 · Feb 8, 2013
Provisional Application 61683192 · Aug 14, 2012
Provisional Application 61896060 · Oct 26, 2013
Provisional Application 61909974 · Nov 27, 2013
Provisional Application 61937344 · Feb 7, 2014
Provisional Application 61940318 · Feb 14, 2014
Provisional Application 61991018 · May 9, 2014
Related Publication 20190316197A1 · Oct 17, 2019
Cited By (1)
US 12,312,640